APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $50,574 | -51.8% | 157,965 | -2.6% | 0.00% | – |
| Q3 2022 | $105,000 | -26.1% | 162,262 | -15.3% | 0.00% | – |
| Q2 2022 | $142,000 | -69.1% | 191,657 | -22.3% | 0.00% | – |
| Q1 2022 | $460,000 | -35.0% | 246,769 | -0.0% | 0.00% | – |
| Q4 2021 | $708,000 | -58.4% | 246,778 | -25.9% | 0.00% | – |
| Q3 2021 | $1,702,000 | +86.4% | 333,153 | +78.0% | 0.00% | – |
| Q2 2021 | $913,000 | +332.7% | 187,161 | +354.3% | 0.00% | – |
| Q1 2021 | $211,000 | – | 41,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Princeton Global Asset Management LLC | 100 | $444 | 0.00% |
| Quent Capital, LLC | 3 | $13 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |